Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosol therapy

D Hess1

  • 1Department of Respiratory Care, Massachusetts General Hospital, Boston, USA.

Respiratory Care Clinics of North America
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Choosing the right aerosol delivery device is crucial for pulmonary disease treatment. Nebulizers generally deliver more medication to the lungs than metered-dose inhalers, especially benefiting acutely ill patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025
Same author

Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures.

The Journal of hospital infection·2021
Same author

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).

Blood cancer journal·2019
Same author

Vacuum-assisted early transanal closure of leaking low colorectal anastomoses: the CLEAN study.

Surgical endoscopy·2017
Same author

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.

Investigational new drugs·2017
Same author

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Respiratory Therapy
  • Pharmacology

Background:

  • Aerosol therapy is a cornerstone in managing pulmonary diseases.
  • Effective drug delivery to the lungs depends on the chosen aerosol device.
  • Metered-dose inhalers are frequently the initial choice for both spontaneously breathing and mechanically ventilated patients.

Purpose of the Study:

  • To compare the lung deposition of medications delivered by different aerosol devices.
  • To inform clinicians on optimal device selection for pulmonary disease treatment.
  • To highlight the impact of device choice on therapeutic outcomes in patients with lung conditions.

Main Methods:

  • Comparative analysis of aerosol delivery devices.
  • Review of literature on lung deposition studies.

Related Experiment Videos

  • Evaluation of drug dosage delivered by nebulizers versus metered-dose inhalers.

    • Main Results:

    • Significant variations exist in the lung dosage delivered by different aerosol devices.
    • Nebulizers typically achieve higher lung delivery compared to metered-dose inhalers for standard prescriptions.
    • These differences in delivery can be critical for managing acutely ill patients requiring effective bronchodilation or medication.

    Conclusions:

    • Device selection significantly impacts aerosolized medication efficacy in pulmonary disease.
    • Nebulizers may offer superior lung drug delivery over metered-dose inhalers, particularly in critical care settings.
    • Clinicians should consider device-specific delivery characteristics to optimize patient treatment.